People and Business News – 4/14

[ad_1]

The latest people and business news from the past month, all in one place.

People News

MMS Holdings announced the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Dr. Breitfeld is currently the chief medical officer for Allterum Therapeutics. Dr. Zeiher has also been the chief medical officer for Astellas Pharma for the past 12 years.

Catawba Research announced the hiring of Andy Silverman, PhD, as chief operating officer. Previously, Silverman worked as EVP, Global Operations for Syneos Health.

Greenphire announced the appointment of Steve Geffon to be its new chief commercial officer. Prior to joining Greenphire, Geffon spent three years in the same role at Science 37.

CluePoints revealed the hiring of Amit Patel as its new CFO. Patel joins CluePoints after serving in the same role at Siteimprove.

Innovative Trials appointed Eloise Moffett as its first commercial vice president. Before joining Innovative Trials, Moffet spent over two years as the senior director of business development for mdgroup.

EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer. Previously, Mackenzie served as the vice president of clinical affairs at M-3 Wake Research.

COTA Inc. announced the hiring of Sandy Leonard as its chief commercial officer. Concurrently, Leonard is the founder of DAISE Consulting LLC.

TOTAL Diversity Clinical Management introduced three new executives to its staff including Gabrielle DeBoer as VP, business development; Jeremy Mitchell as director, business development; and Crystal Thigpen as marketing and communications director.

Recognition

Cluepoints, a provider of Data Quality Oversight Software, has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category. The award category recognizes companies, teams, or individuals leveraging artificial intelligence solutions to improve clinical trials or support successful clinical trial operations.

[ad_2]

Source link